InvestorsHub Logo
Followers 27
Posts 3416
Boards Moderated 0
Alias Born 07/17/2006

Re: None

Monday, 11/13/2006 1:29:04 PM

Monday, November 13, 2006 1:29:04 PM

Post# of 346054
Did PPHM report that they had completed dosing in the 1B trial for HCV? If so, doesn't this represent another step in confirming the safety of Bavi? I seem to recall some expressed concern that the not-fully-human part of Bavi might cause adverse reactions to repeat dosing.

The new posters might be better suited to Ragingbull. They seem a little hysterical for this board.

Paul
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News